Sudoscan in Patients With Autoimmune Disorders
Investigation of Sudoscan in the Evaluation of Small Fiber Dysfunction in Korean Patients With Autoimmune Disorders
1 other identifier
observational
85
1 country
2
Brief Summary
The purpose of this study is to assess the diagnostic utility of Sudoscan in assessing small fiber nerve function, specifically those of the sudomotor, in patients with autoimmune disorders (i.e fibromyalgia and rheumatoid arthritis).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started May 2015
Shorter than P25 for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 27, 2015
CompletedStudy Start
First participant enrolled
May 1, 2015
CompletedFirst Posted
Study publicly available on registry
May 5, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2015
CompletedSeptember 15, 2015
September 1, 2015
4 months
April 27, 2015
September 12, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Sudoscan values
Small fiber function from sweat glands, using Sudoscan
once at time of enrollment
Secondary Outcomes (1)
NCS studies
once at time of enrollment
Study Arms (3)
Fibromyalgia case group
Patients diagnosed with fibromyalgia from the department of rheumatology will be subject to sudoscan evaluation and NCS studies.
Control
Healthy control subjects
Rheumatoid arthritis group
Patients diagnosed with rheumatoid arthritis at the department of rheumatology will be subject to sudoscan evaluation and NCS studies.
Eligibility Criteria
patients who meet the following diagnostic criteria for either 1. Fibromyalgia or 2. Rheumatoid arthritis
You may qualify if:
- A. for healthy control group
- \- No previous diagnosis of peripheral polyneuropathy, fibromyalgia or rheumatoid arthritis
- B. For case group
- Fibromyalgia diagnosed by the rheumatology department
- Rheumatoid arthritis diagnosed by the the rheumatology department.
You may not qualify if:
- For control group
- Participants with previously diagnosed with medical conditions that are known to cause peripheral polyneuropathy (i.e. diabetes mellitus, chronic renal failure, hepatitis, malnutrition), or participants taking medications related to peripheral polyneuropathy(chemoagents, anti Tbc medication) or manifest with symptoms and signs of tingling sensation and gait disturbance that indicate presence of underlying peripheral polyneuropathy.
- For both control and case groups
- Severe skin deficits or swelling that may impede nerve conduction study
- Concomitant presence of mononeuropathy of the extremities.
- Past surgical or traumatic episodes of the foot and distal extremities subject to nerve conduction study
- History of chronic alcoholism, of history of heavy alcohol ingestion with the last 24 hours prior o exam
- Pregnant status at time of evaluation
- presence of pacemaker of defibrillator
- physical inability to lay the palms of the hand and soles of the feet on the plate electrodes.
- scars on the palm and soles of the feet that may impair recording from the plate electrodes
- venous insufficiency, foot swelling or foot ulceration or infection
- Abnormal fasting glucose or Vit B12, thyroid dysfunction, Vit D and abnormal levels of lipid profile, HbA1c \> 7
- Medications with anticholinergics, TCA, anti-histamine, anti-muscarinic medication within the last 48hours
- Patients currently taking Anti Parkinson agents, ranitidine, or other muscle relaxants, beta blockers and atropine
- +1 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Bucheon St Mary's Hospital, Catholic University of Korea
Bucheon-si, Gyenoggido, 420-717, South Korea
Bucheon St Mary's Hospital
Bucheon-si, South Korea
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Su-Jin Monn, M.D., PhD
Catholic University of Korea, College of Medicine Bucheon St. Mary's Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
April 27, 2015
First Posted
May 5, 2015
Study Start
May 1, 2015
Primary Completion
September 1, 2015
Study Completion
September 1, 2015
Last Updated
September 15, 2015
Record last verified: 2015-09